Transperineal Laser Ablation for Benign Prostatic Enlargement: A Systematic Review and Pooled Analysis of Pilot Studies

Author:

Tafuri Alessandro1,Panunzio Andrea23ORCID,De Carlo Francesco1,Luperto Elia1,Di Cosmo Federica1,Cavaliere Arturo1,Rizzo Mino1,Tian Zhe3,Shakir Aliasger4,De Mitri Rita1,Porcaro Antonio2,Cerruto Maria2,Antonelli Alessandro2ORCID,Cormio Luigi5,Carrieri Giuseppe5,Karakiewicz Pierre3,Abreu Andre4,Pagliarulo Vincenzo1

Affiliation:

1. Department of Urology, “Vito Fazzi” Hospital, 73100 Lecce, Italy

2. Department of Urology, Azienda Ospedaliera Universitaria Integrata Verona, University of Verona, 37126 Verona, Italy

3. Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, QC H2X 0A9, Canada

4. Catherine and Joseph Aresty Department of Urology, USC Institute of Urology, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA

5. Department of Urology and Renal Transplantation, University of Foggia, 71122 Foggia, Italy

Abstract

Transperineal laser ablation (TPLA) of the prostate is a new minimally invasive treatment option in men with lower urinary tract symptoms (LUTS) due to benign prostatic enlargement (BPE). The aim of this systematic review was to investigate the efficacy and safety of TPLA in the management of BPE. The primary outcomes were the improvement in urodynamic parameters (maximum urinary flow (Qmax) and postvoiding residue (PVR)) and LUTS relief, assessed using the IPSS questionnaire. The secondary outcomes were the preservation of sexual and ejaculatory functions, assessed with the IEEF-5 and MSHQ-EjD questionnaires, respectively, and rates of postoperative complications. We reviewed the literature for prospective or retrospective studies evaluating the use of TPLA in the treatment of BPE. A comprehensive search in PubMed, Scopus, Web of Science, and ClinicalTrials.gov was performed for English language articles published between January 2000 and June 2022. Pooled analysis of the included studies with available follow-up data for the outcomes of interest was additionally performed. After screening 49 records, six full-text manuscripts were identified, including two retrospective and four prospective non-comparative studies. Overall, 297 patients were included. All the studies independently reported a statistically significant improvement, from baseline, in Qmax, PVR, and IPSS score at each timepoint. Three studies additionally demonstrated that TPLA did not affect sexual function, reporting no change in the IEEF-5 score, and a statistically significant improvement in MSHQ-EjD score at each timepoint. Low rates of complications were recorded in all the included studies. Pooled analysis showed a clinically meaningful improvement in both micturition and sexual outcomes mean values at 1, 3, 6, and 12 months of follow-up, compared with baseline. Transperineal laser ablation of the prostate for the treatment of BPE showed interesting results in pilot studies. However, higher level and comparative studies are needed to confirm its efficacy in relieving obstructive symptoms and preserving sexual function.

Publisher

MDPI AG

Subject

General Medicine

Reference29 articles.

1. (2022, June 27). EAU Guidelines, Management of Non-Neurogenic Male LUTS. Available online: https://uroweb.org/guidelines/management-of-non-neurogenic-male-luts.

2. Hot Topics of the Past Decade: Evolutions and Revolutions in Lower Urinary Tract Symptoms;Cornu;Eur. Urol. Focus,2022

3. Meta-analysis of holmium laser enucleation versus transurethral resection of the prostate for symptomatic prostatic obstruction;Tan;Br. J. Surg.,2007

4. Comparative efficacy and safety of new surgical treatments for benign prostatic hyperplasia: Systematic review and network meta-analysis;Huang;BMJ,2019

5. European Association of Urology Young Academic Urologists (EAU-YAU) Urotechnology and Men’s Health working groups. Anterograde ejaculation preservation after endoscopic treatments in patients with bladder outlet obstruction: Systematic review and pooled-analysis of randomized clinical trials;Cacciamani;Minerva Urol. Nephrol.,2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3